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Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S44Sost mRNA suggesting that Sclerostin might be regulated by Wnt. We
further observed an enhanced expression of Sclerostin in osteoarthritic
cartilage compared to cartilage of control mice.
Conclusions:We here show that Wnt3a increases the catabolic activity
and inhibits the anabolic activity in murine chondrocytes. Sclerostin
alleviates the expression of catabolic genes induced byWnt and rescued
proteoglycan production. Moreover, Sclerostin promotes the cartilage
maintenance through the inhibition of chondrocyte hypertrophy.
Finally, the expression of Sclerostin expression in osteoarthritic mice
suggests that Sclerostin might be involved in the pathophysiology in
cartilage damage and might constitute a target for the prevention of
osteoarthritis.
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ROLE OF STROMAL CELL-DERIVED FACTOR-1 ALPHA ON
ENDOCHONDRAL OSSIFICATION
G. Kim 1,2, S. Han 1,2, Y. Jung 2, S. Usmani 3,4, V. Ulici 3,4,
F. Beier 3,4. 1Daegu fatima Hosp., Daegu, Republic of Korea; 2 Lab. for
arthritis and bone biology, Fatima research Inst., Daegu, Republic of
Korea; 3Dept. of Physiology and Pharmacology, Univ. of Western
Ontario, London, ON, Canada; 4CIHR Group in Skeletal Dev. and
Remodeling, London, ON, Canada
Purpose: The main cellular events of articular chondrocytes during
osteoarthritis are a loss of the traits as permanent cartilage, and
a transition to hypertrophic chondrocytes responding to excessive
stress. Aberrant endochondral ossiﬁcation in the articular cartilage,
such as chondrocyte proliferation, differentiation and apoptosis, are
thought to play an important role in the development of osteoarthritis.
The research about molecular mechanisms controlling the endochon-
dral ossiﬁcation in the growth plate of bone thus can give us an
important clue to understand the pathogenesis of osteoarthritis. Several
lines of evidences suggest that the stromal cell-derived factor-1 alpha
(SDF-1a) has been implicated in osteoarthritis, but their exact mecha-
nisms still remains unclear. In this study, we investigated the roles of
SDF-1a on the endochondral ossiﬁcation.
Methods: Primary chondrocytes and tibial explants from embryonic 15.5
day-oldmicewereculturedwithPBSvehicleor recombinantmouseSDF-1a.
Total RNA was isolated from primary cell cultures using a Qiagen RNeasy
Mini Kit. Real-time PCR analysis was performed using Applied Biosystems
7900 HT Real-Time PCR System and TaqMan Gene Expression Assays for
Sox9, Col2a1, Acan, MMP13, Col10a1, Runx2. Organ culture tissues were
stained with safranin O/fast green and alcian blue/alizarin red, and the
immunohistochemistry was also performed on tissue sections with anti-
Caspase3, anti-MMP13, anti-Runx2, anti-COL10, anti-proliferating chon-
drocyte nuclear antigen (PCNA) and anti-SOX9 antibodies
Results:Primarychondrocyte cultures revealed that SDF-1a signiﬁcantly
increased the expression of aggrecan and Col10a1 which is a marker for
chondrocyte proliferation and hypertrophy, respectively (p<0.05). The
master regulator gene of chondrocyte hypertrophy, Runx2, was also up-
regulated in messenger RNA level by SDF-1a (p<0.05). To gain further
insights into the role of SDF-1a on endochondral ossiﬁcation, we
examined the effects of SDF-1a in tibia organ cultures. The length of
tibias, comparedwith the controls, was signiﬁcantly increased in SDF-1a
treatment group (p<0.05). Immunohistochemical staining of organ
cultures agreed with the morphologic ﬁnding; the expression of PCNA,
themarker for chondrocyteproliferationandSox9markedly increased in
chondrocytes of proliferating zone. In addition to proliferation marker,
type 10 collagen, the marker for hypertrophy and Caspase3, were up-
regulated in hypertrophic zone by SDF-1a.
Conclusions: Our ﬁndings reveal that SDF-1a has an effect on chon-
drocyte proliferation, hypertrophy and apoptosis during endochondral
ossiﬁcation through Sox9 and Runx2. SDF-1a thus may represent
a therapeutic target of osteoarthritis.
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NG2/CSPG4 REGULATES AGGRECANASE AND MMP EXPRESSION IN
HUMAN CHONDROCYTES
N.S. Jamil, A. Azfer, H.E. Sarah, D.M. Salter. Univ. of Edinburgh, Edinburgh,
United Kingdom
Purpose: NG2/CSPG4 is a chondroitin sulphate rich transmembrane
proteoglycan. It is expressed by a number of different cell types
including neuronal cells and melanocytes and appears to be involved inregulation of cell migration, spreading, proliferation and death.
Expression in developing and adult cartilage has been recognised for
some time but less is known of its roles in regulating chondrocyte
function. The purpose of the study was to investigate expression and
interactions of NG2/CSPG4 in chondrocytes and establish whether this
molecule is involved in regulation of gene expression of cartilage
speciﬁc molecules and proteases involved in cartilage breakdown.
Methods: Chondrocytes from osteoarthritic human articular cartilage
(OA), C20A4, an immortalised chondrocyte cell line and JJ012, grade II
chondrosarcoma cell line were used. NG2/CSPG4 expression was
investigated by immunoﬂuorescence, western blotting and RT-PCR.
Interactions within the Golgi complex and endoplasmic reticulumwere
assessed by double immunoﬂuorescence. Biochemical interactions
were assessed by immunoprecipitation and mass spectroscopy. Roles in
gene regulation were studied by shRNA knockdown of NG2/CSPG4 in
JJ012 cells and assessment of gene expression by RTPCR.
Results: NG2/CSPG4 was expressed by all cells studied. Western blot-
ting of extracts from OA chondrocytes showed molecular weight forms
of around 400, 270 and 55kD without chondroitinase treatment and
four forms of 270 238, 117 and 55kD following chondroitinase pre-
treatment. NG2/CSPG4 was distributed predominantly at the cell
surface of JJ012 cells. In OA chondrocytes distribution was both as the
cell surface and within the cytoplasm with double
immunoﬂuorescence indicating that NG2 is localised with the Golgi
complex but not the ER. Immunoprecipitation and mass spectrometry
data demonstrated associations between NG2/CSPG4 and both
collagen VI and thrombospondin in OA chondrocytes. Following NG2
knockdown in JJ012 cells there was no difference in expression of
aggrecan, collagen II and SOX-9. In contrast cells in which NG2/CSPG4
had been knocked down showed decreased expression of MPP3 and
ADAMTS-4, a complete loss of ADAMTS-5 and increased expression of
MMP13.
Conclusions: In this study we have identiﬁed expression of multiple
forms of NG2/CSPG4 in human OA chondrocytes and shown association
of this molecule with type VI collagen and thrombospondin. Loss of
NG2/CSPG4 induced changes in expression of aggrecanases and MMPs.
Altered expression or associations of NG2/CSPG4 with extracellular
ligands or intracellular signalling cascades may be important in the
pathogenesis of OA by regulating proteolytic activity or apoptosis
related pathways.
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ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE (AMPK) INHIBITS
CHONDROCYTE CATABOLIC RESPONSE TO PRO-INFLAMMATORY
CYTOKINES AND UP-REGULATES ANTI-OXIDANT GENES VIA PPARg
COACTIVATOR 1a (PGC-1a) AND FORKHEAD BOX O FACTOR 3
(FOXO3A)
X. Zhao 1, R. Terkeltaub 1, M. Lotz 2, R. Liu-Bryan 1. 1VAMC, UCSD, San
Diego, CA, USA; 2 The Scripps Res. Inst., La Jolla, CA, USA
Purpose: AMPK is a super-regulator of cellular energy homeostasis and
metabolism.We have previously reported that AMPK activity is reduced
in human knee OA articular chondrocytes and in cultured primary
normal chondrocytes stimulated with inﬂammatory cytokines IL-1b
and TNFa. AMPK pharmacologic activators suppress chondrocyte
catabolic responses to IL-1b and TNFa by inhibition of NF-kB activation.
In addition, we observed that AMPK activity is promoted by upstream
kinase LKB1 and inhibited by protein phosphatase PP2Ca in articular
chondrocytes. Because PGC-1a (a master regulator of mitochondria
biogenesis) and FOXO3a (a direct transcriptional regulator of PGC-1) are
downstream targets of AMPK that have been shown to mediate anti-
inﬂammatory effect of AMPK and regulate oxidative stress protect
genes, we tested if PGC-1a and FOXO3a mediate AMPK to inhibit
catabolic responses induced by IL-1b and TNFa, and regulate expression
of anti-oxidant genes such as manganese superoxide dismutase
(MnSOD or SOD2), catalase and thioredoxin in articular chondrocytes.
Methods: Expression of PGC-1a or FOXO3a in normal human knee
articular chondrocytes was knocked down via siRNA transfection. These
knockdown chondrocytes were then stimulated with IL-1b (10 ng/ml)
and TNFa (20 ng/ml). Phosphorylation of p65 (Ser536) NF-kB subunit
was examined at 4 hours after stimulation by Western blot analysis.
Pro-catabolic responses including nitric oxide (NO) generation and
expression of MMP-3 assessed by Griess reaction and Western Blot
analysis, respectively, at 18 hours after stimulation. Additionally, mouse
chondrocytes isolated from femoral head cartilages of AMPKa1
